A FTSE 100 multinational (London-headquartered), Hikma specializes in high‑quality branded and generic medications—including injectable, oral, nasal, and inhalable forms—with over 800 products globally

A global specialty pharma leader with over 150 years of expertise, Mallinckrodt develops and distributes branded and generic products across areas like pain, ADHD, opioid treatment, and critical care, including diagnostic imaging agents.